1. The role of nanosystems in the delivery of glucose-lowering drugs for the preemption and treatment of diabetes-associated atherosclerosis
   Luke James Conroy et al, 2024, American Journal of Physiology-Cell Physiology CrossRef
2. Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis
   Bo Zhu et al, 2024, Vascular Pharmacology CrossRef
3. Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Intima-Media Thickness: Systematic Review and Meta-Analysis
   Abolfazl Akbari et al, 2024, Journal of Diabetes Research CrossRef
4. Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities
   Michelle Yi et al, 2024, International Journal of Molecular Sciences CrossRef
5. From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists
   Bhavarth P. Dave et al, 2024, Molecular Biology Reports CrossRef
6. Liraglutide’s Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis
   Sary Alsanea et al, 2024, Endocrine Practice CrossRef